Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Liabilities and Shareholders Equity: 2010-2012

Historic Liabilities and Shareholders Equity for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $11.8 million.

  • Sonoma Pharmaceuticals' Liabilities and Shareholders Equity rose 31.72% to $11.8 million in Q4 2012 from the same period last year, while for Dec 2012 it was $42.8 million, marking a year-over-year increase of 23.50%. This contributed to the annual value of $7.8 million for FY2012, which is 9.53% down from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Liabilities and Shareholders Equity of $11.8 million as of Q4 2012, which was down 11.66% from $13.4 million recorded in Q3 2012.
  • Over the past 5 years, Sonoma Pharmaceuticals' Liabilities and Shareholders Equity peaked at $13.4 million during Q3 2012, and registered a low of $7.8 million during Q3 2011.
  • In the last 3 years, Sonoma Pharmaceuticals' Liabilities and Shareholders Equity had a median value of $9.2 million in 2011 and averaged $9.6 million.
  • In the last 5 years, Sonoma Pharmaceuticals' Liabilities and Shareholders Equity decreased by 16.55% in 2011 and then surged by 72.51% in 2012.
  • Over the past 3 years, Sonoma Pharmaceuticals' Liabilities and Shareholders Equity (Quarterly) stood at $8.4 million in 2010, then grew by 6.75% to $9.0 million in 2011, then soared by 31.72% to $11.8 million in 2012.
  • Its last three reported values are $11.8 million in Q4 2012, $13.4 million for Q3 2012, and $9.7 million during Q2 2012.